Talk:Pfizer Inc.: Difference between revisions

Revision as of 16:36, 6 July 2023

Operations

How did the idea of the company come about?

Pfizer is a pharmaceutical company that was founded in 1849 by Charles Pfizer and Charles Erhart. The idea for the company came about when Charles Pfizer, a chemist, and his cousin, Charles Erhart, a confectioner, recognized the potential of manufacturing and marketing chemicals for medical purposes. They started by producing and selling santonin, an antiparasitic medication, and quickly expanded their operations to include other pharmaceutical products.

Mission

The mission of Pfizer is to discover, develop, and provide innovative medicines and vaccines that improve the health and well-being of people around the world. Pfizer aims to be a leader in the biopharmaceutical industry by advancing scientific knowledge, investing in research and development, and delivering high-quality healthcare solutions.

Pfizer's mission encompasses several key elements:

1. Discovery and Development: Pfizer is committed to scientific discovery and the development of new medicines and vaccines. They invest in research to uncover breakthroughs, advance scientific knowledge, and explore potential treatment options for various diseases and conditions.

2. Innovation: Pfizer strives for innovation in its approach to healthcare. They seek to develop new and improved therapies, technologies, and solutions that address unmet medical needs and contribute to better health outcomes for patients.

3. Global Impact: Pfizer's mission extends to a global scale. They aim to make a positive impact on the health and well-being of people worldwide. This involves providing access to their medicines and vaccines, particularly in underserved populations, and collaborating with healthcare partners and organizations to address healthcare challenges globally.

4. Patient-Centered Approach: Pfizer is dedicated to putting patients at the center of everything they do. They aim to understand patient needs, provide effective treatments, and improve patient outcomes and quality of life.

By embracing these principles, Pfizer seeks to fulfill its mission of discovering, developing, and delivering innovative medicines and vaccines that contribute to the advancement of healthcare and the improvement of people's lives.

Products

Summary

Pfizer offers a wide range of products and services in the healthcare sector. Their main offerings include prescription medications, vaccines, and consumer healthcare products. They have developed and marketed numerous successful drugs across various therapeutic areas, including cardiovascular diseases, oncology, immunology, neurology, and rare diseases. Some well-known Pfizer products include Viagra, Lipitor, Lyrica, Prevnar, and Xeljanz. They also have a significant presence in the field of vaccines, with notable contributions like the COVID-19 vaccine developed in collaboration with BioNTech. Additionally, Pfizer offers over-the-counter healthcare products for consumers, such as pain relievers, vitamins, and personal care items.

Offering Categories

The main offerings of Pfizer can be categorized into three primary areas: prescription medications, vaccines, and consumer healthcare products. Here's an overview of each category:

1. Prescription Medications

Pfizer develops and markets a broad range of prescription drugs across various therapeutic areas. Some notable offerings include:

- Lipitor (atorvastatin): A medication used to lower cholesterol levels.

- Viagra (sildenafil): A medication for the treatment of erectile dysfunction.

- Lyrica (pregabalin): A drug prescribed for neuropathic pain, fibromyalgia, and certain types of seizures.

- Celebrex (celecoxib): A nonsteroidal anti-inflammatory drug (NSAID) used for pain relief and inflammation reduction.

- Xeljanz (tofacitinib): A medication for the treatment of rheumatoid arthritis and other autoimmune conditions.

2. Vaccines

Pfizer has a significant presence in the development and production of vaccines. Notable vaccine offerings include:

- COVID-19 Vaccine (developed in collaboration with BioNTech): A highly effective vaccine to prevent COVID-19.

- Prevnar 13 (pneumococcal 13-valent conjugate vaccine): A vaccine to protect against pneumococcal diseases, including pneumonia.

3. Consumer Healthcare Products

Pfizer also offers a range of over-the-counter healthcare products for consumers. These include:

- Advil (ibuprofen): An over-the-counter pain reliever and fever reducer.

- Centrum: A line of multivitamin and mineral supplements.

- Caltrate: A brand of calcium supplements for bone health.

- ChapStick: A popular lip balm product.

It's important to note that Pfizer's product portfolio may vary based on geographic regions and evolving market demands.

Research report example

Take a look at this commended research report on Tesla, Inc. from the Stockhub platform: https://stockhub.co/research/Tesla,_Inc. While it has garnered positive feedback, remember that it's simply a reference - there's no obligation to adhere strictly to its style or content.

Key source(s) of information

A prime source of insightful information about this company is the company itself. Specifically, the annual report provides comprehensive details about its financial status and business progress. You can access this valuable resource at the following link: Pfizer's Annual Report. Another key source is that of the company's competitors.

Risks

Following risks or uncertainties include the following:

Risks related to business, industry and operations


	Risk
	The outcome to meet anticipated pre-clinical and clinical endpoints, and to be able to meet regulatory approval with the possibility of potential unfavourable pre-clinical or clinical data.
	Able to address comments and concerns from regulatory authorities and to be able to obtain approval for new products.
	Claims and concerns in regards to the safety of efficiacy of products and product candidates.
	Competition from new product entrants, including but not limited to; generic products, private label products and biosimilars.
	Impact of public health outbreaks impacting on business, operations and financial conditions.
	Impact of increased presence of counterfeit medicines or vaccines in the pharmaceutical supply chain.
	Impact of increased presence of counterfeit medicines or vaccines in the pharmaceutical supply chain.

2. Risks related to Government Regulation and Legal Proceedings


	Risks
	The impact of any U.S. healthcare reform involving cost controls affecting publicly funded health programs that may be implemented.
	Governmental regulations affecting operations.

3. Risks involving Intellectual Property, Technology and Security


	Risks
	Business disruption, theft of information that result in an integrity comprimise resulting from a cyber-attack.
	Risks to products, patents and other IP including, claims of invalidity, patent infringemen and pressure or regulatory action by the government or large stakeholders.

@@ Line 58: / Line 58: @@
    - ChapStick: A popular lip balm product.
 It's important to note that Pfizer's product portfolio may vary based on geographic regions and evolving market demands.
-== Market ==
-=== Total addressable market size: ===
-Research shows that approximately 95% of the world has health issues or problems [https://www.sciencedaily.com/releases/2015/06/150608081753.htm#:~:text=Over%2095%25%20of%20the%20world's,than%20five%20ailments%20%2D%2D%20ScienceDaily]. Currently, the world population is at 7.8 billion people. This means that 95% of 7.8 billion people is 7 billion, 410 and million is the addressable market size [https://www.sciencedaily.com/releases/2015/06/150608081753.htm#:~:text=Over%2095%25%20of%20the%20world's,than%20five%20ailments%20%2D%2D%20ScienceDaily].
-According to Statista, the global pharmaceutical industry had an annual revenue of $1.42 trillion in 2021 [https://pharmanewsintel.com/features/comparing-global-pharmaceutical-markets-the-us-uk-and-china#:~:text=According%20to%20Statista%2C%20the%20global,and%20the%20COVID%2D19%20pandemic.].
-In terms of market share, Pfizer held 5% of the world's prescription drug market in 2019 [https://www.statista.com/statistics/309425/prescription-drugs-market-shares-by-top-companies-globally/#:~:text=Pfizer%20held%20five%20percent%20of,the%20global%20market%20until%202026.].
-=== Serviceable addressable market size: ===
-Here, the total addressable market size is the patient population that was treated with Pfizer vaccines and medicines. This is estimated to be about 1.3 billion patients around the world [https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2022/files/Pfizer_Annual_Review.pdf]
-In 2022, the industry is expected to generate 1.14 trillion U.S. dollars in prescription drug revenue worldwide ([https://www.statista.com/statistics/309387/global-total-prescription-drug-revenue-projection/#:~:text=In%202022%2C%20the%20industry%20is,the%20treatment%20of%20rare%20diseases.].
-=== Serviceable Obtainable Market: ===
-The healthcare industry is worth $808 billion in the United States as of 2021 [https://www.crossrivertherapy.com/healthcare-industry-statistics#:~:text=The%20healthcare%20industry%20is%20worth,revenue%20comes%20from%20patient%20care.].
-== Competition ==
-Despite Pfizer being the leading companies in the biotechnology and pharmaceutical industry, several other large, global drug manufacturers are in competition with Pfizer. These companies include Johnson and Johnson, Roche Holding AG, Novo Nordisk, Merck and Co, AbbVie Inc, and Eli Lilly and Co.
-In FY 2022, Pfizer made $31.37 billion in net income out of $100.33 billion in annual revenue. The company's market capitalization was $227 billion as of market close on March 24, 2023 [https://s28.q4cdn.com/781576035/files/doc_financials/2022/ar/PFE-2022-Form-10K-FINAL-%28without-Exhibits%29.pdf].  Market cap is used to determine a company's size and then evaluate the company's financial performance to other companies of various sizes. In investing, companies with larger market capitalizations are often safer investments as they represent more established companies with generally longer history in business carrying less risk than small-cap companies.
-# Johnson and Johnson:
-* Market cap: $423 billion
-* FY 2022 Revenue: $95 billion
-* FY 2022 Net income: $17.9 billion
-* Top drug by revenue (FY 2022): Darzalex
-* Revenue from top drug (FY 2022): $7.9 billion [https://www.investor.jnj.com/asm/2022-annual-report]
-Johnson and Johnson is known for its health products, pharmaceuticals and medical devices.
-. Novo Nordisk A/S (NVO):
-* Market cap: $349 billion [https://www.investopedia.com/markets/quote?tvwidgetsymbol=NVO]
-* FY 2022 Revenue: $43.5 billion
-* FY 2022 Net income: $16.9 billion
-* Top drug by revenue (FY 2022): Ozempic
-* Revenue from top drug (FY 2022): $5.7 billion [https://www.novonordisk.com/investors/financial-results.html#results2023]
-Novo Nordisk is a Norweigan pharmaceutical company that focuses on treating diabetes, obesity and other serious chronic diseases and conditions. Ozempic was Novo Nordisk's top selling drug in 2022 which is an insulin therapy delivered by injection.
-. Eli Lilly and Co:
-* Market cap: $440 billion [https://www.investopedia.com/markets/quote?tvwidgetsymbol=LLY]
-* FY 2022 Revenue: $28.5 billion
-* FY 2022 Net income: $6.2 billion
-* Top drug by revenue (FY 2022): Trulicity
-* Revenue from top drug (FY 2022): $5.7 billion [https://investor.lilly.com/static-files/2f9b7bb1-f955-448d-baa2-c4343d39ee62]
-Eli Lilly is a global drug manufacturing company which focuses on discovering, developing, manufacturing and marketing human pharmaceutical products. The company's top selling drug in FY 2022 was Trulicity which is used to treat type 2 diabetes.
-. Abbvie Inc.
-* Market Cap: $242 billion [https://www.investopedia.com/markets/quote?tvwidgetsymbol=ABBV]
-* FY 2022 Revenue: $58.1 billion
-* FY 2022 Net Income: $11.8 billion
-* Top Drug by Revenue (FY 2022): Humira
-* Revenue from Top Drug (FY 2022): $18.6 billion ([https://investors.abbvie.com/static-files/e3047152-75b3-44b3-95a8-18e4fa991768]
-AbbVie is a global biopharmaceutical company engaged in research and development, manufacturing, commercializing and selling innovation medicines and therapies. Its medical products span a range of healthcare-related areas such as immuology, oncology, neuroscience, etc.
-. Merck and Co. Inc
-* Market Cap: $289 billion
-* FY 2022 Revenue: $59.3 billion
-* FY 2022 Net Income: $16.4 billion
-* Top Drug by Revenue (FY 2022): Keytruda
-* Revenue from Top Drug (FY 2022): $20.9 billion [https://s21.q4cdn.com/488056881/files/doc_financials/2022/ar/b390be48-92bf-4595-96da-ac5cd7c3d92e-%281%29.pdf]
-The company offers prescription medicines, vaccines, biologic therapies, and animal health products. Its two operating segments are pharmaceutical and animal health.
-Overall, Pfizer's largest competitor is Johnson and Johnson. Johnson and Johnson may not generate the same amount of revenue from its products but its market cap and total revenue make it a strong competitor.
-That being said, Pfizer is different from other companies because Pfizer continually emphasises innovation and its multi-billion dollar investment in R and D results in a strong and differentiated product pipeline. The organizational effectiveness of the company is constantly improving by continuously educating patients, physicians, payers and global health authorities on the benefits and risks of medicines and vaccines. Pfizer continues to evaluate, adapt and improve the organisation and business practice in order to meet customer and public needs. Pfizer establishes a "first-to-market" for biosimilar products to provide customers a lower-cost alternative immediately when available as well as providing the company with higher sales and profitability until other competititors enter the market. Pfizer's intellectual property and continuous medicine development are its competitive advantages over other companies [https://www.investopedia.com/ask/answers/052015/who-are-pfizers-pfe-main-competitors.asp].
 == Research report example ==